| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total assets | 439,771 | 470,593 | ||
| Accumulated other comprehensive loss | 235 | -45 | ||
| Total stockholders equity | 315,329 | 344,561 | ||
| Total liabilities and stockholders equity | 439,771 | 470,593 | ||
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)